In this edition
- Providers sanctioned for Medicare fraud had higher rates of patient deaths
- New regulations in 2020 expand role of PAs in Medicare
- Over half of seriously sick Medicare enrollees struggle with medical bills
- Medicare and Medigap premiums spiked almost 200% since 2000
- VA, CMS collaborate to protect veterans from Medicare abusers
- CMS proposes coverage of DNA tests for breast and ovarian cancer
Welcome to Medicare Heads Up, a regular feature intended to deliver state and national Medicare-related headlines that will keep consumers abreast of developments that affect their coverage and costs. This week:
Providers sanctioned for Medicare fraud had higher rates of patient deaths
Medicare beneficiaries who received care from a provider who was later excluded from Medicare were found to experience higher rates of emergency room admissions and deaths. The study tracked the patient outcomes of providers described as Fraud and Abuse Perpetrators (FAPs), who were later barred from Medicare due to fraud, patient harm, or license revocation. Although the topic of Medicare fraud is an ongoing financial battle, the JAMA study was the first to examine the human toll left by convicted perpetrators of Medicare fraud.
New regulations in 2020 expand role of PAs in Medicare
To increase patient access to prescribing level physicians, new regulations will relax Medicare rules which require a Physician’s Assistant (PA) to practice only under a supervising physician. The change – which takes effect January 1 – will allow PAs to practice independently up to the full scope allowed by state law, which in many areas includes the ability to prescribe and diagnose. The increased role of PAs in Medicare reflects a larger national trend in America’s healthcare provider spectrum, which currently has a significant shortage of primary care physicians accelerated by the growing number of retirees.
Over half of seriously sick Medicare enrollees struggle with medical bills
Over half (53%) of seriously ill Medicare beneficiaries had trouble paying their medical bills. The recent study conducted by the journal of Health Affairs shed light on the financial reality of seriously ill Medicare enrollees – once thought to be a gold standard of American health insurance. Instead of security and solvency, the surprising results showed that more than 30% of beneficiaries had exhausted savings for medical bills, 27% had been contacted by a collection agency, and 23% were unable to pay for daily needs such as food, heat and housing. The study evaluated seriously ill patients, described as those whose condition over the past three years required multiple hospital stays and appointments with over three physicians.
Medicare and Medigap premiums spiked almost 200% since 2000
Between 2000 and 2019, Medicare Part B premiums increased 198 percent and Medigap premiums averaged a 135 percent spike. The runaway costs of Medicare programs contrasted sharply with the 50 percent Cost-Of-Living Adjustment (COLA) in Social Security for the same period. In 2019, the average beneficiary spent $5,000 ($416 monthly) on Medicare premiums, which has led many beneficiaries to raid their retirement and savings accounts. (And 48 percent of households aged 55 and over report no retirement savings, further compounding the problem.)
VA, CMS collaborate to protect veterans from Medicare abusers
In an attempt to eliminate substandard care at Department of Veterans Affairs (VA) facilities and through its growing number of purchased-care programs, the VA will collaborate with the Center for Medicare and Medicaid Services (CMS) on a Medicare Sanctions program. Scheduled at reoccurring intervals, the VA will utilize advanced CMS data analytics to compare provider data and flag infractions that will include, among others: abusive billing practices, felony convictions and prescribing violations. The Medicare Sanctions program is the first of many planned anti-fraud data-share initiatives between both federal agencies.
CMS proposes coverage of DNA tests for breast and ovarian cancer
Medicare beneficiaries diagnosed with certain forms of ovarian and breast cancer may soon have coverage for Next Generation Sequencing (NGS) diagnostic tests. Built upon DNA sequencing, NGS testing works by creating a genetic profile of the patient’s cancer cells to identify inherited mutations, allowing physicians to utilize gene-specific treatments. Medicare generally does not cover preventive DNA testing unless specified by law, and then only for certain conditions in limited circumstances.
Although Medicare may start covering more genetic testing, beneficiaries should be wary if anyone other than their own doctor offers Medicare-covered genetic testing. A recent Medicare DNA fraud scheme was busted by federal authorities in September, leading to the arrest of 35 individuals – including nine physicians. The racket involved promising genetic cancer screening tests to Medicare beneficiaries in exchange for their Medicare billing information.
Jesse Migneault is a journalist and editor who has written about business, government and healthcare – including public and private-payer health insurance. His articles have appeared in HealthPayerIntelligence, the Hartford Courant, Portsmouth Herald, Seacoastonline.com, Foster’s Daily Democrat, and York County Coast Star.
In addition, his work has been cited by health industry stakeholders such as the Eugene S. Farley Health Policy Center, Association of Healthcare Journalists, American Academy of Actuaries, Kaiser Permanente, blueEHR, San Diego Law Review, Medicare Agent News, healthjournalism.org, and Concierge Medicine among others.